DENTSPLY International (XRAY) : Mycio Wealth Partners scooped up 25,158 additional shares in DENTSPLY International during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 11, 2016. The investment management firm now holds a total of 165,852 shares of DENTSPLY International which is valued at $10.1 Million.DENTSPLY International makes up approximately 1.81% of Mycio Wealth Partners’s portfolio.
Other Hedge Funds, Including , Shinko Asset Management Ltd. boosted its stake in XRAY in the latest quarter, The investment management firm added 215 additional shares and now holds a total of 632 shares of DENTSPLY International which is valued at $38,653.Blackrock Group Ltd boosted its stake in XRAY in the latest quarter, The investment management firm added 575,736 additional shares and now holds a total of 1,706,657 shares of DENTSPLY International which is valued at $104.4 Million. DENTSPLY International makes up approx 0.06% of Blackrock Group Ltd’s portfolio. Sivik Global Healthcare added XRAY to its portfolio by purchasing 30,000 company shares during the most recent quarter which is valued at $1.9 Million. DENTSPLY International makes up approx 0.81% of Sivik Global Healthcare’s portfolio.World Asset Management Inc boosted its stake in XRAY in the latest quarter, The investment management firm added 3,252 additional shares and now holds a total of 23,376 shares of DENTSPLY International which is valued at $1.4 Million. DENTSPLY International makes up approx 0.05% of World Asset Management Inc’s portfolio.
DENTSPLY International opened for trading at $61.07 and hit $62.575 on the upside on Monday, eventually ending the session at $62.26, with a gain of 1.80% or 1.1 points. The heightened volatility saw the trading volume jump to 15,92,065 shares. Company has a market cap of $14,583 M.
On the company’s financial health, DENTSPLY International reported $0.69 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on May 6, 2016. Analyst had a consensus of $0.62. The company had revenue of $772.60 million for the quarter, compared to analysts expectations of $778.36 million. The company’s revenue was up 17.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.59 EPS.
Investors should note that on Apr 8, 2016, DENTSPLY International announced a cash dividend of $0.0775. The company’s management has announced Jun 22, 2016 as the ex-dividend date and fixed the record date on Jun 24, 2016. The payable date has been fixed on Jul 8, 2016.
Many Wall Street Analysts have commented on DENTSPLY International. Company shares were Reiterated by Barrington Research on May 13, 2016 to “Outperform”, Firm has raised the Price Target to $ 68 from a previous price target of $62 .DENTSPLY International was Downgraded by Morgan Stanley to ” Equal-Weight” on Mar 24, 2016. DENTSPLY International was Initiated by Credit Suisse to “Outperform” on Mar 16, 2016.
DENTSPLY International Inc. is a designer developer manufacturer and marketer of a range of consumable dental products for the professional dental market. It operates through three segments: Dental Consumable and Certain International Businesses; Dental Specialty and Laboratory and Certain Global Distribution Businesses and Healthcare and Emerging Markets Businesses. All the segments are primarily engaged in the design manufacture and distribution of dental and medical products in four product categories. Its Dental Consumable Products consist of dental supplies and devices and small equipment used in dental offices. Its Dental Laboratory Products are used in the preparation of dental appliances by dental laboratories. Its Dental Specialty Products are specialized treatment products used within the dental office and laboratory settings. Its Consumable Medical Device Products consist mainly of urology catheters certain surgical products medical drills and other products.